Several studies have reported phosphatidylinositol-3-kinase α catalytic subunit (PIK3CA) gene amplification, deletions and somatic missense mutations in several types of human cancers, including colorectal, breast and hepatocellular carcinomas where these mutations occur in up to 30% of the tumours examined (12–14). Here, PIK3CA is linked to neoplasm.